- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0087940

About Omnibrx Biotechnologies Private Limited
Data last updated:
Omnibrx Biotechnologies Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 02 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U29306GJ2016PTC092297. Its GSTIN is 24AACCO3300N1ZO (Gujarat).
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹2.38 Lakh. It is led by directors Ravindra Dhirubhai Patel (Managing Director) and Heenaben Ravindrakumar Patel.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 Block A Times Corporate Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.31 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹11.13 Cr (net margin -119.5%) and EBITDA of -₹9.5 Cr (EBITDA margin -102%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 54% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: OmniBRx Biotechnologies. As per MCA filings, the company has open charges of ₹1.13 Cr on record. The company has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.
Omnibrx Biotechnologies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0087940). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omnibrx.com.
Company details
Recognitions & Rankings of Omnibrx Biotechnologies
Contact details
Omnibrx Biotechnologies Private Limited's registered office is in Ahmedabad, Gujarat. Its website is omnibrx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressCorporate House No. 5 Block A Times Corporate Park, Opp. Cooper Stone Thalej – Shilaj Road, Ahmedabad, Gujarat, India – 380059
- IndustryLife Sciences, Biotechnology
To see the full contact details of Omnibrx Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Omnibrx Biotechnologies operates one associated brand: OmniBRx Biotechnologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Single-use bioreactors are manufactured for vaccine and cell therapy production. | omnibrx.com |
Business activity
The main business activity of Omnibrx Biotechnologies is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C10 | Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment |
To see the full business activity and turnover split of Omnibrx Biotechnologies Private Limited, buy the company report.
Financials of Omnibrx Biotechnologies Private Limited
FY 2024 filings availableOmnibrx Biotechnologies Private Limited reported revenue of ₹9.31 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 24% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.13 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -102% | ||||
| Net Profit Margin | -119.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Omnibrx Biotechnologies Private Limited, buy the company report.
Board of directors of Omnibrx Biotechnologies Private Limited
Omnibrx Biotechnologies has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Heenaben Ravindrakumar Patel | Director | 27 Sep 2016 | 10 Years 1 Months | Current |
| Ravindra Dhirubhai Patel | Managing Director | 02 Jun 2016 | 10 Years 5 Months | Current |
Auditor
Omnibrx Biotechnologies Private Limited is audited by B S R and Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R and Co. | FY 2023 | 128510W |
Shareholding
The shareholding of Omnibrx Biotechnologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Omnibrx Biotechnologies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Aug 2021 | 100486667 | Hdfc Bank Limited | ₹12.51 Lakh | Open | |
| 16 Aug 2019 | 100292600 | Sidbi | ₹1 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Omnibrx Biotechnologies Private Limited has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Funding round · Series A | ₹29.99 Cr | Investors: SIDBI Ventures |
| Jul 2020 | Funding round · Seed | ₹99.9 Lakh | Investors: Venture Center |
| Mar 2020 | Rights issue | ₹21 Lakh | Investors: an individual |
| Nov 2018 | Rights issue | ₹68 Lakh | Investors: 4 individuals |
| Sep 2017 | Rights issue | ₹46.8 Lakh | Investors: 4 individuals |
To see the full deal history of Omnibrx Biotechnologies Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Omnibrx Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omnibrx Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Omnibrx Biotechnologies Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 23 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Omnibrx Biotechnologies Private Limited, buy the company report.
GST
Omnibrx Biotechnologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCO3300N1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Omnibrx Biotechnologies Private Limited, buy the company report.
Recent activity
Omnibrx Biotechnologies Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Chintan Kaushik Gandhi ceased to be Nominee Director on 24 Jun 2025.
Frequently asked questions
Omnibrx Biotechnologies is an active private limited company based in Ahmedabad, Gujarat, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 02 June 2016 (10+ years old) and is registered under CIN U29306GJ2016PTC092297.
Omnibrx Biotechnologies has 2 current directors:
- Ravindra Dhirubhai Patel - Managing Director
- Heenaben Ravindrakumar Patel - Director
The latest financial statements of Omnibrx Biotechnologies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Omnibrx Biotechnologies is 24AACCO3300N1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Omnibrx Biotechnologies is U29306GJ2016PTC092297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omnibrx Biotechnologies was incorporated on 02 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Omnibrx Biotechnologies has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.
Chintan Kaushik Gandhi ceased to be Nominee Director on 24 Jun 2025. Debraj Banerjee ceased to be Nominee Director on 22 Nov 2024. Priti Dilip Rathi ceased to be Nominee Director on 30 Mar 2023. Omnibrx Biotechnologies has 7 board changes on record in total.
Yes, Omnibrx Biotechnologies is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0087940).
Omnibrx Biotechnologies can be reached through the website omnibrx.com. Its registered office is in Ahmedabad, Gujarat, India.

